Elixia

In this episode, Mike S. with CSSi, an Elixia company, discusses best practices for building trust and transparency with clinical trial participants. You'll see the impact of trust-building initiatives and patient-centric communication on retention, medication adherence, and overall trial success. Tune in to hear how CSSI is reshaping patient engagement—ensuring participants feel valued, informed, and supported every step of the way ? https://lnkd.in/g5q9JU8F

Great to catch up with old friends and make new connections here at #SCOPESummit in Orlando! From insightful conversations to fun moments, it’s been an incredible experience so far. ? We’re here for one more day, so don’t miss your chance to stop by Booth 333! Whether you have a wish list or just want to say hello, we’d love to chat and explore how we can help. #CSSi #SCOPE2025 #ClinicalResearch #PatientEngagement #Innovation

See you in Orlando! ?? Our team is ready to have meaningfull conversations that lead to collaborative partnerships! ?? Elixia sites are focused on key therapeutic areas: ??Cardiovascular/ Nephrology / Dialysis ??Complex Metabolic / Obesity / Diabetes ??Neurology / Psychiatry Harry Alcorn PharmD, Chief Scientific Officer, will be on site to share how our world-class, Phase 1 site in Tampa, Florida can support your special population studies. {Specific to Renal, Hepatic, Dialysis, Psychiatry and more}. Looking for a patient recruitment partner that can offer end-to-end solutions that deliver results? The CSSi team will be in attendance! Mike S. Teresa DeHaemer Ken Wallace, MBA

Elixia and CSSi will be in Orlando for the SCOPE Summit 2025! Our team will be on hand to share exciting updates regarding our US clinical site organization expansion and our patient recruitment innovation! Schedule a meeting with Mike S., Brandi Buzzetta, Adrienne Rossi, Harry Alcorn PharmD, Ken Wallace, MBA or Teresa DeHaemer at? [email protected]. #Scope2025 #SiteNetworkPartners #PatientRecruitment #PatientsFirst

As we wrap up another year in clinical research, we reflect on the progress we've made and the lives we have touched. This season reminds us of the importance of collaboration, innovation, and the community we have formed. From all of us at Elixia, we wish you and your loved ones a very Happy Holiday season, full of happiness and cheer. May the new year bring even greater clinical trial access to the patients and communities we serve. ? #PatientCentric #HappyHolidays #ClinicalResearch #Elixia

Dr. Rizwana Mohseni is attending the World Congress Insulin Resistance Diabetes & Cardiovascular Disease (WCIRDC) December 12th - 14th in Los Angeles. Dr. Mohseni will provide valuable insights and share her expertise on insulin-resistant diabetes and cardiovascular disease. To schedule time with Dr. Mohseni, please contact Anne Arriaga at [email protected]. #InsulinResistance #Cardiology #ClinicalTrials #Elixia

This season, we pause to reflect on the relationships and collaborations that inspire us every day. We’re incredibly grateful for our partners, clients, and team members who help drive advancements in clinical research and make a meaningful impact on patients’ lives. From all of us at Elixia, we wish you and your loved ones a joyful and restful Thanksgiving filled with warmth, gratitude, and connection. Here’s to continuing to make a difference together. ?? #Thanksgiving #Gratitude #ClinicalResearch #Elixia

"We are excited to standardize Elixia's site network with Realtime's Enterprise CTMS and Devana Propel solutions. The platform approach allows for unified training of team members, visibility of sales pipeline through startup, and integration for CTMS, regulatory documents, and eSource"- Dustin Owen, CEO We're thrilled to announce that Elixia is officially live with RealTime eClinical Solutions- a powerful solution that will revolutionize the way we manage clinical trials. By integrating this advanced system, Elixia is taking trial management to the next level with: ? Streamlined Operations: Simplifying workflows and enhancing efficiency across all trial phases. ? Enhanced Data Integrity: Ensuring accuracy and compliance for more reliable outcomes. ? Optimized Collaboration: Improving communication and coordination among teams for smoother execution. This step forward reflects our commitment to innovation and excellence in clinical trial management. With RealTime, Elixia continues to lead the way in delivering industry-leading results for our clients and partners. #ClinicalTrials #Elixia #InnovationInResearch #RealTime #TrialManagement #ClinicalResearchExcellence

At Elixia, we are dedicated to advancing clinical research that improves the lives of those living with chronic obstructive pulmonary disease (COPD). This condition impacts millions worldwide, yet continued research and awareness bring hope for better treatments and improved quality of life. ? Through our innovative patient recruitment strategies and unwavering support for clinical trial success, we’re proud to play a role in driving progress for COPD studies. Let’s work together to raise awareness, support ongoing research, and advocate for those affected by COPD. Together, we can breathe life into a healthier future. #WorldCOPDAwarenessDay #ClinicalResearch #COPD #Elixia

Tune in to discover how Elixia’s agility and efficiency, combined with our top-tier recruitment and regulatory standards, make us a true standout in the clinical trial industry. #elixiaexellence #clinicaltrials